Bristol-Myers Squibb

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross domestic product. McKinsey & Co. follows suit, noting AI could generate 30% efficiency gains and cost savings in the pharmaceutical sector and trigger financial gains of up to $110 billion annually.

Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

First Ascent Biomedical, a Miami biotech company and cancer researcher, will receive $2 million in funding from the Florida Cancer Innovation Fund. The grant is intended to accele

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,

Tevogen Bio has expanded its partnership with Microsoft, aiming to further its AI-centred collaboration and advance its predictive precision T-cell targeting technology, PredicTcell.

A £225m supercomputer is using artificial intelligence (AI) to develop new drugs and vaccines. When it is fully operational this summer, the Isambard-AI computer in Bristol will be the most powerful supercomputer in the UK. On Monday, Prime Minister Sir Keir Starmer unveiled plans to "unleash AI" across the UK in an effort to boost growth.